Skin + Me lands £10 million to expand its online skin care subscription

By Amanda Pauley | Published: 16-Feb-2023

The investment will boost the D2C brand’s prescription-only skin care strategy and marketing activity as customer demand soars

Skin + Me has secured £10m to further develop its personalisation skin care strategy as customer demand ramps up. 

The D2C skintech start-up – which delivers bespoke, dermatologist designed treatments using prescription-only ingredients – closed a Series B funding round with capital investor Octopus Ventures.

The investment will boost innovations within its online prescription service and accelerate activity in new marketing channels.

Skin + Me’s business has grown 100% year-on-year since it launched in 2020.

It has prescribed millions of products to hundreds of thousands of customers. 

The business is now cash generative.

Skin + Me’s business has grown 100% year-on-year

Skin + Me’s business has grown 100% year-on-year

The start-up also experienced a 50% uptake in its range of supplementary cosmetic moisturisers and cleansers, which launched last year.

“We have seen consumer awareness for prescription-only ingredients such as tretinoin grow exponentially,” said Horatio Cary, CEO of Skin + Me. 

“We expect the £140bn global skin care spend to shift quickly towards prescription-strength ingredients and [we are] ideally placed… to take advantage of this trend.” 

Will Gibbs, Healthtech Partner at Octopus Ventures, commented: “Increased awareness in prescription ingredients and a growing trend towards personalisation has transformed the skin care market. 

“Skin + Me lead the charge with its accelerated growth, reflecting a step change that has seen hyper-educated consumers shun off-the-shelf products in favour of highly efficacious solutions.” 

Read more:


You may also like